Key Client Fiduciary Advisors, LLC Agenus Inc Transaction History

Key Client Fiduciary Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$0.53 - $0.93 $125,345 - $219,945	236,500 Added 37.99%	858,969 $498,000
Q4 2023 Jan 09, 2024	BUY	$0.63 - $1.14 $54,956 - $99,445	87,233 Added 16.3%	622,469 $516,000
Q3 2023 Nov 14, 2023	SELL	$1.12 - $1.88 $7,112 - $11,938	-6,350 Reduced 1.17%	535,236 $604,000
Q2 2023 Jul 13, 2023	BUY	$1.31 - $2.04 $13,081 - $20,371	9,986 Added 1.88%	541,586 $866,000
Q1 2023 Apr 25, 2023	BUY	$1.45 - $2.95 $59,812 - $121,687	41,250 Added 8.41%	531,600 $808,000
Q4 2022 Jan 17, 2023	SELL	$2.02 - $3.25 $32,572 - $52,406	-16,125 Reduced 3.18%	490,350 $0
Q3 2022 Oct 12, 2022	BUY	$1.96 - $3.14 $7,840 - $12,560	4,000 Added 0.8%	506,475 $1.04 Million
Q2 2022 Jul 19, 2022	BUY	$1.3 - $2.64 $101,127 - $205,365	77,790 Added 18.32%	502,475 $975,000
Q1 2022 Apr 18, 2022	BUY	$2.35 - $3.47 $193,640 - $285,928	82,400 Added 24.07%	424,685 $1.05 Million
Q4 2021 Mar 01, 2022	BUY	$2.92 - $5.74 $999,472 - $1.96 Million	342,285 New	342,285 $1.1 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Key Client Fiduciary Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Key Client Fiduciary Advisors, LLC with notifications on news.